Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy — Thomas Waldmann (DIVISION OF BASIC SCIENCES - NCI
: A major development over the past 5 years and a future direction is our development of long-acting IL-15. Long-acting IL-15 (MS-IL-15): For IL-15 to be effectively used this activity requires contin
| Project title | Interleukin-15 Production for Treatment of Patients with Metastatic Malignancy |
|---|---|
| Project number | 1ZIBBC010906-14 |
| PI name | Thomas Waldmann |
| Institution | DIVISION OF BASIC SCIENCES - NCI |
| Funding mechanism | ZIB |
| Agency | NCI |
| Award amount | $2.43M |
| Fiscal year | 2021 |
| Abstract | : A major development over the past 5 years and a future direction is our development of long-acting IL-15. Long-acting IL-15 (MS-IL-15): For IL-15 to be effectively used this activity requires contin |
| Key terms | <ATLL><Abscission><Academy><Address><Adult T-Cell Leukemia><Adult T-Cell Leukemia/Lymphoma><Adult T- |
$799/mo
Try GrantRadar →